Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 120600
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.120600
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.120600
Figure 4 Forest plots showing the comparative diagnostic performance (pooled odds ratio) of intracystic glucose vs carcinoembryonic antigen.
A: Accuracy, with pooled odds ratio (OR): 3.35 (95%CI: 2.34-4.80, I² = 92.87%); B: Sensitivity, with pooled OR: 9.36 (95%CI: 6.72-13.06, I² = 0%); C: Specificity, with pooled OR: 0.43 (95%CI: 0.26-0.70, I² = 0%). CEA: Carcinoembryonic antigen; CI: Confidence interval; OR: Odds ratio.
- Citation: Rizzo GEM, Infantino G, Marchegiani G, Machicado JD, Del Chiaro M, Tarantino I, Rossi G, Arcidiacono PG, Vanella G, Guilabert L, Nikolić S, Capurso G. Intracystic glucose is superior to carcinoembryonic antigen in diagnosing mucinous pancreatic cysts in genomic era: Systematic review and meta-analysis. World J Clin Oncol 2026; 17(5): 120600
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/120600.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.120600